Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy

Chimeric antigen receptor (CAR)-T cell therapy represents a landmark advance in personalized cancer treatment. CAR-T strategy generally engineers T cells from a specific patient with a new antigen-specificity, which has achieved considerable success in hematological malignancies, but scarce benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zaoqu, Zhou, Zhaokai, Dang, Qin, Xu, Hui, Lv, Jinxiang, Li, Huanyun, Han, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475465/
https://www.ncbi.nlm.nih.gov/pubmed/36168626
http://dx.doi.org/10.7150/thno.76854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475465/
https://www.ncbi.nlm.nih.gov/pubmed/36168626
http://dx.doi.org/10.7150/thno.76854

Ejemplares similares